In this study, we assess whether a class 1 HDAC inhibitor (4-acetamido-N-(2-aminophenyl) benzamide [CI-994]) or virus-mediated HDAC2 knockdown enhances synapse formation and motor function of the affected paw after brain injury in mice. This evidence concerns the gene HDAC9 and brain injury.